MedPath

Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.

Not Applicable
Completed
Conditions
Haemophilia
Developing Countries
Interventions
Other: Education
Diagnostic Test: Improve biological diagnosis and follow-up of haemophilia
Drug: Implement haemostatic non substitutive care of haemophilia
Other: Implement non haemostatic care of haemophilia
Registration Number
NCT03054662
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Brief Summary

This study aims to make an inventory of the condition and care of patients with haemophilia and carriers for haemophilia in Ivory Coast and to promote the use non substitutive strategies that are not costly and available in Ivory Coast, to improve the management of haemophilia in this country. The purpose of this project is to evaluate the extent to which the active promotion of these various measures will improve the care of patients with haemophilia and carriers in Ivory Coast.

Detailed Description

1. Establish a baseline of the condition of haemophilia in Ivory Coast (number of patients, demographics, reassessment of diagnosis, joint status...).(year 1)

2. Develop tools to assess the intervention (eg transcultural validation of QoL questionnaires, develop booklets to record bleedings...). (year 1)

3. Intervention phase that will focus on education of patients and their family, education of caregivers, training of the laboratory to the diagnosis of haemophilia and promotion of non substitutive strategies to improve haemophilia care in Ivory Coast (DDAVP, antifibrinolytics, physiotherapy, dental care,...).

4. Follow-up phase during 2 years.

5. Outcome analysis

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
142
Inclusion Criteria
  • Males with severe and moderate haemophilia A and B in Ivory Coast (any age).
  • Females over 12 years who are carriers for severe and moderate haemophilia A and B in Ivory Coast.
Exclusion Criteria

subjects not willing to participate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Carriers for HaemophiliaEducationCarriers for severe and moderate haemophilia A and B in Ivory Coast
Patients with HaemophiliaImplement haemostatic non substitutive care of haemophiliaMale patients with severe and moderate haemophilia A and B in Ivory Coast
Patients with HaemophiliaImplement non haemostatic care of haemophiliaMale patients with severe and moderate haemophilia A and B in Ivory Coast
Patients with HaemophiliaImprove biological diagnosis and follow-up of haemophiliaMale patients with severe and moderate haemophilia A and B in Ivory Coast
Patients with HaemophiliaEducationMale patients with severe and moderate haemophilia A and B in Ivory Coast
Carriers for HaemophiliaImplement haemostatic non substitutive care of haemophiliaCarriers for severe and moderate haemophilia A and B in Ivory Coast
Carriers for HaemophiliaImprove biological diagnosis and follow-up of haemophiliaCarriers for severe and moderate haemophilia A and B in Ivory Coast
Primary Outcome Measures
NameTimeMethod
Improve haemophilia care in Ivory Coast2 years after intervention

Compare the pain assessment before and after the intervention phase

Improve haemophilia diagnosis of haemophilia in Ivory Coast3 years

Compare the number of patients with haemophilia between the beginning and the end of the study

Improve knowledge about haemophilia in Ivory Coast2 years after intervention

Compare the knowledge queestionnaires about haemophilia before and after the intervention phase

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de Yopougon

🇨🇮

Abidjan, Côte D'Ivoire

© Copyright 2025. All Rights Reserved by MedPath